NEW YORK (Reuters Health) – When patients with early active rheumatoid arthritis (RA) start rituximab along with methotrexate (MTX), they have significantly better physical function and health-related quality…
NEW YORK (Reuters Health) – The selective T-cell co-stimulation modulator abatacept safely and effectively treats psoriatic arthritis (PsA) in many patients, according to a report in the December…
NEW YORK (Reuters Health) – Abatacept, an agent that modifies the costimulatory signal required for T-cell activation, does not increase malignancy rates in patients with rheumatoid arthritis (RA),…
NEW YORK (Reuters Health) – In patients receiving glucocorticoids for inflammatory diseases, adverse events are very common, even at low to medium doses, according to a meta-analysis by…
NEW YORK (Reuters Health) – A 12-year study in middle-aged adults suggests that knee pain is frequently the first sign of knee osteoarthritis. “Knee pain is common, and…
NEW YORK (Reuters Health) – Anti-tumor necrosis factor (TNF) agents do not increase the risk of cancer during the first few years of use for rheumatoid arthritis, according…
NEW YORK (Reuters Health) – The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density (BMD) and preventing vertebral fractures in patients with…
NEW YORK (Reuters Health) – Opioid analgesics should not be used in elderly patients with osteoarthritis even if their pain is severe, because the associated risks are so…
Daniel Mazanec, MD, FACP, FACR, Associate Director, Center for Spine Health Cleveland Clinic, discusses medical acupuncture and its role in western medicine treating headache, musculoskeletal disorders including osteoarthritis.…
NEW YORK (Reuters Health) – New research from France indicates that patients using anti-tumor necrosis factor (TNF) monoclonal antibody therapy are at greater risk for developing tuberculosis than…
Rachel Rohde, Orthopedic Surgeon, discusses the treatment options for basal joint arthritis prior to consultation with an orthopedic surgeon. Sponsored by The Doctor’s Channel
NEW YORK (Reuters Health) – Rituximab (Rituxan) has been implicated in 57 cases of progressive multifocal leukoencephalopathy (PML) in HIV-negative patients diagnosed with hematologic malignancies or autoimmune diseases,…
